Study of Pregnancy Outcomes in Women Exposed to Rimegepant During Pregnancy
Study of Pregnancy Outcomes in Women Exposed to Rimegepant During Pregnancy
Active, not recruiting · NCT05198245 · Registry updated 2026-08-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Pregnancy Outcomes in Women Exposed to Rimegepant During Pregnancy | brain disorder, central nervous system disorder, headache disorder, hypnic headache, migraine disorder, nervous system disorder | Active, not recruiting | Not stated | 2026-08-25 | NCT05198245 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Carelon Research, Inc | 1 |
| Optum, Inc. | 4 |
| Pfizer | 431 |
| RTI Health Solutions | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Pfizer | New York | United States | 12 |